A Clinical-Genetic (CG) Circulating Tumor DNA (ctDNA)-based Prognostic Model for Predicting Overall Survival (OS) in Metastatic Castrate-Resistant Prostate Cancer (mCRPC) Men Treated with Potent Androgen Reception Inhibition (Alliance)
- Citation:
- J Clin Oncol vol 24 (16_suppl) 5007
- Meeting Instance:
- ASCO 2024
- Year:
- 2024
- Type:
- Abstract
- Sub type:
- Oral
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epreprint
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- Yes
- Parents:
- None
- Children:
- 4376
- Pharmas:
- Astellas
- Grants:
- U10CA180821, U10CA180882; 5R01-CA256157
- Corr. Author:
- Authors:
- Susan Halabi Bin Luo Siyuan Guo Todd Knutson Anna Kobilka Jacqueline Lyman Himisha Beltran Charles J. Ryan W. Kevin Kelly Emmanuel Antonarakis Jonathan E. Rosenberg Matthew Galsky Eric J. Small Michael J. Morris Scott M. Dehm Andrew J. Armstrong
- Networks:
- CA136, LAPS-MA036, LAPS-NC010, LAPS-NY016, MN022, NY021
- Study
- Alliance-A031201
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: